Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Address
30 TECHNOLOGY DRIVE
WARREN, NJ 07059
Founded
2004
Number of Employees
135
Website
http://www.aquestive.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)